Vincenzo Fierro, Rocco L Valluzzi, Claudia Banzato, Ma A Plaza, Montserrat Bosque, Marcel Íbero, Luis A Z Echeverría, Maurizio Mennini, Lamia Dahdah, Roser de Castellar, Gloria Tort, Jesus Jiménez
OBJECTIVES: Infants with cow's milk allergy (CMA) are in need of a substitute formula up to 2 years. The are three requisites for a substitute of milk in CMA: tolerability, nutritional adequacy, and cost-effectiveness. We evaluate here the tolerability of a new amino acid-based infant formula for the management of CMA. METHODS: In a phase III/IV prospective, multicentre, open-label, international study, infants and children with immunoglobulin E-mediated CMA were exposed to a diagnostic double-blinded, placebo-controlled food challenge with a new amino acid formula by Blemil Plus Elemental using Neocate as the placebo...
June 2020: Immunity, Inflammation and Disease